Buscar

01/10/2021 COVID-19 in Solid Organ Transplant Recipients in Spain Throughout 2020: Catching the Wave?
Coll, E, Fernandez-Ruiz, M, Padilla, M, Moreso, F, Hernandez-Vicente, A, Yanez, I, Molina, M, Vazquez-Sanchez, T, Crespo, M, Facundo, C, Rodriguez-Ferrero, ML, Fuentes, MCR, Loinaz, C, Bernal, G, Melilli, E, Bravo, C, Diekmann, F, Llado, L, Garcia-Alvarez, TM, Salcedo, M, Beneyto, I, Castells, L, Alonso, R, Rodriguez-Benot, A, Diaz-Corte, C, Graus, J, Ortiz-Bautista, C, Garcia-Cosio, MD, Hinojal, R, Pena, L, Dominguez-Gil, B. COVID-19 in Solid Organ Transplant Recipients in Spain Throughout 2020: Catching the Wave?. TRANSPLANTATION. 2021; 105(10)DOI:10.1097/TP.0000000000003873. PMID:34241988. IF:5.385(Q1/2D).
01/10/2021 Monitoring of gene expression in tacrolimus-treated de novo renal allograft recipients facilitates individualized immunosuppression: Results of the IMAGEN study
Sommerer, C, Brunet, M, Budde, K, Millan, O, Perich, LG, Glander, P, Meuer, S, Zeier, M, Giese, T. Monitoring of gene expression in tacrolimus-treated de novo renal allograft recipients facilitates individualized immunosuppression: Results of the IMAGEN study. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2021; 87(10)DOI:10.1111/bcp.14794. PMID:33620734. IF:3.716(Q2/5D).
01/10/2021 Impact of nutritional vitamin D supplementation on parathyroid hormone and 25-hydroxyvitamin D levels in non-dialysis chronic kidney disease: a meta-analysis
Bover, J, Gunnarsson, J, Csomor, P, Kaiser, E, Cianciolo, G, Lauppe, R. Impact of nutritional vitamin D supplementation on parathyroid hormone and 25-hydroxyvitamin D levels in non-dialysis chronic kidney disease: a meta-analysis. Clinical Kidney Journal. 2021; 14(10)DOI:10.1093/ckj/sfab035. PMID:34603696. IF:5.860(Q1/2D).
01/09/2021 Long-term follow-up of renal function in patients treated with migalastat for Fabry disease
Bichet, DG, Torra, R, Wallace, E, Hughes, D, Giugliani, R, Skuban, N, Krusinska, E, Feldt-Rasmussen, U, Schiffmann, R, Nicholls, K. Long-term follow-up of renal function in patients treated with migalastat for Fabry disease. Molecular Genetics and Metabolism Reports. 2021; 28DOI:10.1016/j.ymgmr.2021.100786. PMID:34401344. IF:2.082(Q4/9D).
01/09/2021 Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19
Buxeda, A, Arias-Cabrales, C, Perez-Saez, MJ, Cacho, J, Pelegrin, SC, Melilli, E, Aladren, MJ, Galeano, C, Lorenzo, I, Mazuecos, A, Saura, IM, Franco, A, Ruiz-Fuentes, MD, Sanchez-Camara, LA, Siverio, O, Martin, ML, Gonzalez-Garcia, E, Lopez, V, Martin-Moreno, PL, Moina, I, Berrio, EM, Moreso, F, Portoles, JM, Santana-Estupinan, R, Zarraga, S, Canal, C, Sanchez-Alvarez, E, Pascual, J, Crespo, M. Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19. Kidney International Reports. 2021; 6(9)DOI:10.1016/j.ekir.2021.06.023. PMID:34250317. IF:6.234(Q1/2D).
01/09/2021 A urinary stone from the early medieval site of Riner, Catalonia
Oller, NA, Gracia-Gracia, S, Cugat, JB, Vicente, IG, Exposito, IM, Casafont, JL. A urinary stone from the early medieval site of Riner, Catalonia. International Journal of Paleopathology. 2021; 34DOI:10.1016/j.ijpp.2021.07.006. PMID:34315047. IF:1.448(Q3/8D).
01/08/2021 Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantation
Millan, O, Rovira, J, Guirado, L, Espinosa, C, Budde, K, Sommerer, C, Pineiro, GJ, Diekmann, F, Brunet, M. Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantation. CLINICAL IMMUNOLOGY. 2021; 229DOI:10.1016/j.clim.2021.108792. PMID:34217849. IF:10.190(Q1/2D).
01/08/2021 Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria
Savige, J, Storey, H, Watson, E, Hertz, JM, Deltas, C, Renieri, A, Mari, F, Hilbert, P, Plevova, P, Byers, P, Cerkauskaite, A, Gregory, M, Cerkauskiene, R, Ljubanovic, DG, Becherucci, F, Errichiello, C, Massella, L, Aiello, V, Lennon, R, Hopkinson, L, Koziell, A, Lungu, A, Rothe, HM, Hoefele, J, Zacchia, M, Martic, TN, Gupta, A, van Eerde, A, Gear, S, Landini, S, Palazzo, V, Al-Rabadi, L, Claes, K, Corveleyn, A, Van Hoof, E, van Geel, M, Williams, M, Ashton, E, Belge, H, Ars, E, Bierzynska, A, Gangemi, C, Lipska-Zietkiewicz, BS. Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria. EUROPEAN JOURNAL OF HUMAN GENETICS. 2021; 29(8)DOI:10.1038/s41431-021-00858-1. PMID:33854215. IF:5.351(Q1/2D).